Go Deep
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 22,611 | -31.5 | 1.72 | 0.72 | 93.17 |
| Oct 2026 | 22,876 | -30.0 | 1.68 | 0.72 | 91.01 |
| Oct 2026 | 21,859 | -30.0 | 1.66 | 0.72 | 89.98 |
Camlin Fine Sciences Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 5,198,790,000.0 | 4,248,112,000.0 | 4,571,967,000.0 | 4,598,169,000.0 |
| Net Profit | -317,060,000.0 | 882,019,000.0 | -362,299,000.0 | -143,840,000.0 |
| EPS | -1.6 | 4.6 | -1.9 | -0.8 |
Camlin Fine Sciences Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 17,112,208,000.0 | 15,977,599,000.0 | 14,362,323,000.0 | 16,713,011,000.0 | — |
| Net Profit | 276,272,000.0 | -1,390,459,000.0 | -927,534,000.0 | 521,064,000.0 | — |
| EPS | 1.5 | -8.0 | -5.5 | 3.4 | — |
Camlin Fine Sciences Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 23,239,028,000.0 | 20,237,868,000.0 | 19,517,240,000.0 | 20,600,987,000.0 | — |
| Total Liabilities | 13,230,962,000.0 | 11,490,075,000.0 | 10,947,736,000.0 | 12,360,143,000.0 | — |
| Total Equity | 10,408,801,000.0 | 9,016,730,000.0 | 8,647,508,000.0 | 8,193,740,000.0 | — |
Owes vs Owns
Camlin Fine Sciences Limited owed ₹0.57 for every ₹1 it owned in Mar 2026, down from ₹0.60 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.57× | 0.57× | 0.56× | 0.60× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Camlin Fine Sciences Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 4.8%Receivables 16.1%Inventory 21.7%Fixed assets (tangible) 28.6%Intangible assets 11.3%Long-term investments 1.1%Other assets 16.5%
How it's funded — Mar 2026
Short-term debt 15.7%Long-term debt 13.0%Payables 21.7%Other liabilities 6.4%Shareholders' equity 43.1%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 111.8 | 143.3 | 81.2 | 95.2 |
| Receivables | 373.0 | 328.2 | 285.2 | 304.6 |
| Inventory | 503.7 | 526.9 | 512.7 | 568.1 |
| Fixed assets (tangible) | 663.8 | 658.9 | 807.2 | 838.6 |
| Intangible assets | 262.3 | 57.7 | 59.9 | 66.2 |
| Long-term investments | 24.8 | 21.2 | 6.2 | 6.2 |
| Other assets | 384.5 | 287.6 | 199.4 | 181.2 |
| Liabilities & equity | ||||
| Short-term debt | 365.5 | 347.8 | 324.9 | 371.5 |
| Long-term debt | 302.6 | 268.3 | 332.7 | 408.1 |
| Payables | 505.2 | 406.7 | 324.6 | 288.4 |
| Other liabilities | 149.8 | 126.1 | 112.5 | 168.1 |
| Shareholders' equity | 1,000.8 | 874.8 | 857.0 | 824.1 |
| Net tangible assets | 778.6 | 844.0 | 804.9 | 753.2 |
Camlin Fine Sciences Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 820,686,000.0 | 229,959,000.0 | 1,389,818,000.0 | 508,982,000.0 | — |
| Investing Activities | -529,518,000.0 | -753,498,000.0 | -664,979,000.0 | -1,246,256,000.0 | — |
| Financing Activities | -246,323,000.0 | 761,699,000.0 | -859,716,000.0 | 596,581,000.0 | — |